Management of corneal perforations in dry eye disease: Preferred practice pattern guidelines.


Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
04 2023
Historique:
medline: 10 4 2023
entrez: 7 4 2023
pubmed: 8 4 2023
Statut: ppublish

Résumé

Corneal perforations in eyes with dry eye disease (DED) are difficult to manage due to the interplay of several factors such as the unstable tear film, surface inflammation, and the underlying systemic disease affecting the wound healing process, and the eventual outcome. A careful preoperative examination is required to identify the underlying pathology, and status of ocular surface and adnexa, rule out microbial keratitis, and order appropriate systemic workup in addition to assessing the perforation itself. Several surgical options are available, which include tissue adhesives, multilayered amniotic membrane grafting (AMT), tenon patch graft (TPG), corneal patch graft (CPG), and penetrating keratoplasty (PK). The choice of procedure depends upon the size, location, and configuration of the perforation. In eyes with smaller perforations, tissue adhesives are effective treatment modalities, whereas AMT, TPG, and CPG are viable options in moderate-sized perforations. AMT and TPG are also preferable in cases where the placement of a bandage contact lens may be a challenge. Large perforations require a PK, with additional procedures such as tarsorrhaphy to protect the eyes from the associated epithelial healing issues. Conjunctival flaps are considered in eyes with poor visual potential. The management of the acute condition is carried out in conjunction with measures to improve the tear volume bearing in mind the chances of delayed epithelialization and re-perforation in these cases. Administration of topical and systemic immunosuppression, when indicated, helps improve the outcome. This review aims to facilitate clinicians in instituting a synchronized multifaceted therapy for the successful management of corneal perforations in the setting of DED.

Identifiants

pubmed: 37026269
pii: IndianJOphthalmol_2023_71_4_1373_373494
doi: 10.4103/IJO.IJO_2826_22
pmc: PMC10276684
doi:

Substances chimiques

Tissue Adhesives 0

Types de publication

Practice Guideline Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1373-1381

Déclaration de conflit d'intérêts

None

Références

Cornea. 2019 May;38(5):658-661
pubmed: 30681523
Cornea. 2019 Apr;38(4):454-462
pubmed: 30702468
Cornea. 2007 Dec;26(10):1195-9
pubmed: 18043175
AMA Arch Ophthalmol. 1958 Nov;60(5):880-8
pubmed: 13582332
Indian J Ophthalmol. 2009 Sep-Oct;57(5):341-4
pubmed: 19700870
Cornea. 2019 Aug;38(8):951-954
pubmed: 31276458
Can J Ophthalmol. 2020 Apr;55(2):99-106
pubmed: 31712000
Am J Ophthalmol. 2016 Mar;163:167-173.e1
pubmed: 26701271
Ophthalmology. 1992 Apr;99(4):622-7
pubmed: 1584581
ACS Appl Bio Mater. 2021 Jan 18;4(1):533-544
pubmed: 35014304
Ophthalmology. 2003 Feb;110(2):291-8
pubmed: 12578769
Br J Ophthalmol. 2006 Jul;90(7):924
pubmed: 16782960
Asia Pac J Ophthalmol (Phila). 2020 Dec;9(6):524-532
pubmed: 33181548
Curr Opin Ophthalmol. 2020 Jul;31(4):293-301
pubmed: 32412959
Br J Ophthalmol. 2018 Jun 11;:
pubmed: 29891734
Saudi J Ophthalmol. 2021 Feb 27;34(3):216-217
pubmed: 34085019
Cornea. 2013 Oct;32(10):1326-30
pubmed: 23974883
Cornea. 2010 Sep;29(9):971-5
pubmed: 20539218
Surv Ophthalmol. 2004 Jan-Feb;49(1):51-77
pubmed: 14711440
Eye (Lond). 2009 Jun;23(6):1288-94
pubmed: 18949010
Ophthalmology. 2013 Apr;120(4):682-6
pubmed: 23290983
Am J Ophthalmol. 1980 Jun;89(6):795-802
pubmed: 7386556
Semin Ophthalmol. 2022 Apr 3;37(3):330-344
pubmed: 34423717
Clin Ophthalmol. 2018 Apr 09;12:677-681
pubmed: 29670328
Eur J Ophthalmol. 2006 Nov-Dec;16(6):791-7
pubmed: 17191183
Med Eng Phys. 2019 Sep;71:68-78
pubmed: 31201014
Clin Exp Ophthalmol. 2000 Dec;28(6):437-42
pubmed: 11202468
Cornea. 2019 Jun;38(6):668-673
pubmed: 30865049
Nepal J Ophthalmol. 2020 Jan;12(23):56-65
pubmed: 32799240
Br J Ophthalmol. 2015 Jan;99(1):59-63
pubmed: 25053758
Am J Ophthalmol. 2001 Mar;131(3):324-31
pubmed: 11239864
Exp Ther Med. 2017 Aug;14(2):1109-1113
pubmed: 28810564
Cornea. 2008 Oct;27(9):988-91
pubmed: 18812759
Ophthalmology. 1995 Apr;102(4):576-85
pubmed: 7724175
Ophthalmology. 2020 Jan;127(1):128-133
pubmed: 31561880
Sci Rep. 2021 Jun 21;11(1):13007
pubmed: 34155280
J Cataract Refract Surg. 2007 Jun;33(6):959-61
pubmed: 17531686
Eye Contact Lens. 2003 Oct;29(4):258-61
pubmed: 14555906
J Ocul Pharmacol Ther. 2020 Apr;36(3):137-146
pubmed: 32175799
Case Rep Ophthalmol Med. 2012;2012:173793
pubmed: 22701193
Semin Ophthalmol. 2005 Apr-Jun;20(2):113-28
pubmed: 16020351
Surv Ophthalmol. 2020 Jan - Feb;65(1):1-11
pubmed: 31306671
Expert Opin Drug Saf. 2007 Nov;6(6):637-40
pubmed: 17967152
Cornea. 2006 Jan;25(1):44-6
pubmed: 16331040
Chin Med J (Engl). 2016 Aug 5;129(15):1817-21
pubmed: 27453231
Front Med (Lausanne). 2020 Oct 07;7:575834
pubmed: 33117835
Cornea. 2009 May;28(4):451-5
pubmed: 19411966
BMJ Case Rep. 2017 Nov 23;2017:
pubmed: 29170188
Indian J Ophthalmol. 2020 Jan;68(1):7-14
pubmed: 31856457
Surv Ophthalmol. 2021 Mar-Apr;66(2):290-307
pubmed: 32866469
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1179-1184
pubmed: 28409225
Br J Ophthalmol. 2018 Oct;102(10):1328-1335
pubmed: 29581352
Cornea. 2021 May 1;40(5):618-623
pubmed: 33055550
Indian J Ophthalmol. 2021 Jan;69(1):69-73
pubmed: 33323577
Indian J Ophthalmol. 2009 Sep-Oct;57(5):371-9
pubmed: 19700876
Semin Ophthalmol. 2022 May 19;37(4):462-470
pubmed: 34932431
Am J Ophthalmol. 1950 Mar;33(3 Pt. 2):24
pubmed: 15410449
Cornea. 2005 May;24(4):369-77
pubmed: 15829790
Bioengineering (Basel). 2022 Jan 28;9(2):
pubmed: 35200405
Cornea. 1999 May;18(3):262-4
pubmed: 10336025
J Formos Med Assoc. 2006 Apr;105(4):334-9
pubmed: 16618614
Prog Retin Eye Res. 2018 Sep;66:107-131
pubmed: 29698813
Med Hypothesis Discov Innov Ophthalmol. 2019 Fall;8(3):163-176
pubmed: 31598519
Cornea. 2013 May;32(5):e137-8
pubmed: 23407321
Biomaterials. 2018 Jul;171:57-71
pubmed: 29684677
J Indian Med Assoc. 2012 Jan;110(1):29-30, 39
pubmed: 23029828
Exp Ther Med. 2018 Mar;15(3):2711-2718
pubmed: 29456673
Invest Ophthalmol Vis Sci. 2011 Jul 01;52(7):4859-65
pubmed: 21571679
Biomolecules. 2021 Apr 02;11(4):
pubmed: 33918484
Arch Ophthalmol. 1983 Jun;101(6):958-60
pubmed: 6683097
Cornea. 2000 May;19(3):313-9
pubmed: 10832690
Br J Ophthalmol. 2017 May;101(5):634-639
pubmed: 27503392
Doc Ophthalmol. 1996-1997;93(3):237-45
pubmed: 9550352
Surv Ophthalmol. 2011 Nov-Dec;56(6):522-38
pubmed: 22117886
Ophthalmologica. 2002 Jul-Aug;216(4):249-55
pubmed: 12207127
Ophthalmology. 2002 Apr;109(4):694-703
pubmed: 11927426
Indian J Ophthalmol. 2006 Jun;54(2):89-94
pubmed: 16770024
J Mater Chem B. 2022 Apr 13;10(15):2912-2925
pubmed: 35297911
Int J Ophthalmol. 2012;5(1):88-91
pubmed: 22553762
Biomaterials. 2017 Sep;140:115-127
pubmed: 28646685
Eye (Lond). 2006 Jan;20(1):84-9
pubmed: 15803178
Cornea. 2020 Nov;39(11):1371-1376
pubmed: 32732701
Int J Surg Case Rep. 2021 Jun;83:106046
pubmed: 34098186
Ocul Surf. 2019 Jan;17(1):50-54
pubmed: 30157458
Can J Anaesth. 1993 Sep;40(9):835-8
pubmed: 8403178
BMC Ophthalmol. 2014 Aug 08;14:97
pubmed: 25102918

Auteurs

Anahita Kate (A)

Shantilal Sanghvi Cornea Institute, KVC Campus, L V Prasad Eye Institute, Vijaywada, Andhra Pradesh, India.

Rashmi Deshmukh (R)

Shantilal Sanghvi Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Pragnya R Donthineni (PR)

Shantilal Sanghvi Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Namrata Sharma (N)

R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.

Rasik B Vajpayee (RB)

Vision Eye Institute; Royal Victorian Eye and Ear Hospital; University of Melbourne, Melbourne, Australia.

Sayan Basu (S)

Shantilal Sanghvi Cornea Institute, KAR Campus, L V Prasad Eye Institute, Hyderabad, Telangana, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH